With the enforcement of the EU AI Act, healthcare and life sciences companies face new pressure to ensure their AI systems are trained on the right data – with the right controls in place – to ensure they remain compliant in one of the most highly regulated industries in the world.
In this video, we explore how Immuta and Snowflake deliver governed, automated data provisioning at enterprise scale, so pharmaceutical companies can reduce risk while accelerating research and innovation.
What you’ll learn:
- Why the EU AI Act makes data governance more critical than ever for pharma
- How Immuta’s integration with Snowflake automates data provisioning and access control for tens of thousands of users
- The role of automation in preventing human error in large-scale data governance frameworks
- How to ensure auditability and traceability of who accessed what data and when
- Why automation frees up data teams to focus on science and innovation, not permissions
Pharma organizations like Roche rely on Immuta and Snowflake to ensure compliance, prevent data exposure, and build trust, while giving researchers fast, governed access to the data they need. The result? Fewer data silos, stronger compliance, and more resources for innovation.
Learn more about accelerating Snowflake data access in healthcare.